A detailed history of Kistler Tiffany Companies, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 127 shares of NVO stock, worth $15,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127
Previous 109 16.51%
Holding current value
$15,336
Previous $17,000 17.65%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$155.98 - $172.65 $2,807 - $3,107
18 Added 16.51%
127 $20,000
Q3 2022

Nov 09, 2022

BUY
$95.28 - $116.93 $95 - $116
1 Added 0.93%
109 $11,000
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $103 - $121
1 Added 0.93%
108 $12,000
Q2 2021

Aug 04, 2021

BUY
$67.66 - $84.76 $67 - $84
1 Added 0.94%
107 $9,000
Q2 2020

Jul 20, 2020

BUY
$58.54 - $67.94 $6,205 - $7,201
106 New
106 $7,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.